Technology News and Research

RSS

NanoString secures exclusive worldwide license to develop products for breast cancer intrinsic subtyping

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has secured an exclusive worldwide license from Bioclassifier, LLC to develop in vitro diagnostic and research products for breast cancer intrinsic subtyping.

From NanoString Technologies 7 Dec 2010

Campaign to inoculate millions across Africa against meningitis kicks off in Burkina Faso

On Monday, a campaign started in Burkina Faso to "inoculate tens of millions of West Africans with a new vaccine in what scientists hope will be the beginning of the end of ravaging meningitis epidemics" across the continent, the New York Times reports.

7 Dec 2010

Research team creates digital version of Broselow tape for children

A well-known paper-based medical chart used by pediatric emergency personnel across America is undergoing a 21st century boost in an collaborative effort between Virginia Tech's College of Engineering, Roanoke-based Carilion Clinic Children's Hospital, and the physician who created the original method some 25 years ago.

7 Dec 2010

Smoking's effect on face induces women to quit the habit

Seeing the effect smoking will have on their faces shocks women into giving up the habit, research from Staffordshire University has revealed.

7 Dec 2010

Quantros to demonstrate new patient safety improvement solutions at IHI National Forum

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, will demonstrate several new patient safety improvement solutions at the 22nd Annual Institute for Healthcare Improvement National Forum on Quality Improvement in Health Care, Dec. 5 to 8 in Orlando, FL.

7 Dec 2010

Health experts, mobile service providers discuss potential for mobile health in Africa at summit

"Some 80 health professionals and telecom operators [met last week for the mHealth Africa Summit] in the Ghanaian capital Accra to explore ways to use mobile phones for better healthcare delivery," IRIN reports in an article that details a variety of successful projects relaying health information through cell phones in Africa. The article describes how mobile phones are being used in Africa to educate populations about HIV/AIDS, tuberculosis and improve maternal health, as well as to track medicines and other health supplies, including mosquito nets.

7 Dec 2010

PAREXEL International opens two new Clinical Logistics Services facilities

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has opened two new Clinical Logistics Services facilities in emerging regions for biopharmaceutical development. PAREXEL's new depot in Singapore and ancillary warehouse in Russia will support its clients in more effectively managing their global clinical trial supply requirements.

From Parexel 6 Dec 2010

Fraunhofer USA CMB receives FDA approval to initiate Phase I clinical trial of H5N1 influenza vaccine

Fraunhofer USA Center for Molecular Biotechnology announced today it has received approval from the Food and Drug Administration to proceed with the first human clinical trial of plant-produced H5N1 influenza vaccine.

6 Dec 2010

Asuragen, Novartis to develop ARQ BCR-ABL1 RNA IS Calibrators, laboratory software reporting tools

Asuragen, Inc. announced today that it has entered into an exclusive agreement with Novartis to develop worldwide Armored RNA Quant BCR-ABL1 RNA International Scale Calibrators and laboratory software reporting tools, intended to aid laboratories with standardization of BCR-ABL1 RT-qPCR testing to the International Scale. As part of this agreement, Asuragen will develop and, if successful, distribute the ARQ BCR-ABL1 IS RNA Calibrators and software reporting tools to laboratories globally directly or through its distributors.

6 Dec 2010

HHS, U.S. Treasury Department recognize Integrated Medical Systems' technolgy

The medical technology developed by Integrated Medical Systems, Inc., has been recognized by the U.S. Department of Health and Human Services and the U.S. Treasury Department as a "qualified therapeutic discovery." The designation earns the company a grant to off-set its development efforts. The Qualifying Therapeutic Discovery Project designation and grant is provided for under the Patient Protection and Affordable Care Act of 2010.

6 Dec 2010

GP Medical, Beijing Yuande named in Deloitte Technology Fast 500 Asia Pacific 2010 program

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that its wholly-owned subsidiaries, Beijing GP Medical Technologies Co., Ltd. and Beijing Yuande Bio-Medical Engineering Co., Ltd., have been ranked 12th and 415th, respectively, in the Deloitte Technology Fast 500 Asia Pacific 2010 program.

6 Dec 2010

MBH receives prestigious 2010 Healthcare IT Summit Innovation Award

Autonomy Corporation plc, a global leader in infrastructure software for the enterprise, today announced that Autonomy Meaning Based Healthcare received the prestigious 2010 Healthcare IT Summit Innovation Award for "Solution With Greatest Market Potential." Autonomy was selected for this award by attendees at the 2010 Healthcare IT Summit, including leading healthcare delivery organizations and insurance providers such as Massachusetts General Hospital, University of Pennsylvania Health System, Johns Hopkins Healthcare, UnitedHealth Group, and CIGNA.

6 Dec 2010

HP, mPedigree Network introduce life-saving service to fight counterfeit drugs in Africa

HP and African social enterprise mPedigree Network have introduced a potentially life-saving service that targets counterfeit pharmaceuticals by enabling people in Nigeria and Ghana to easily check the authenticity of their malaria medication.

6 Dec 2010

First patient dosed with rFVIIIFc in A-LONG trial

Biogen Idec and Swedish Orphan Biovitrum today announced that the first patient has been dosed with the companies' long-lasting recombinant Factor VIII Fc fusion protein (rFVIIIFc) in a global registrational clinical trial. The study, called A-LONG, is an open-label, multicenter, Phase 2/3 study designed to evaluate the safety, pharmacokinetics and efficacy of rFVIIIFc in previously-treated hemophilia A patients.

6 Dec 2010

Merrion Pharmaceuticals announces oral drug delivery Feasibility and Option agreement

Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the commencement of an oral drug delivery Feasibility and Option agreement with one of the world's top ten biggest pharmaceutical companies. The agreement will evaluate the ability of Merrion's patented GIPET technology to boost the bioavailablity of three of the 'big pharma' company's compounds.

6 Dec 2010

Researchers adapt gene chip microarray technology to study glycans

Sugar molecules coat every cell in our bodies and play critical roles in development and disease, yet the components of these "glycans" have been difficult for scientists to study, because of their complexity.

6 Dec 2010

Cerner, Baxa sign strategic reseller agreement for DoseEdge Pharmacy Workflow Manager

Cerner Corporation and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge Pharmacy Workflow Manager. The agreement enables Cerner to market and resell the Baxa DoseEdge System as part of an integrated Cerner offering. Cerner clients now have access to a broader suite of solutions and certified integration for dose tracking from compounding to delivery.

6 Dec 2010

Marine life-inspired anti-microbial surfaces

Taking a leaf from animals like dolphins and pilot whales that are known to have anti-fouling skins, researchers from A*STAR's Industrial Consortium On Nanoimprint (ICON) are using nanotechnology to create synthetic, chemical-free, anti-bacterial surfaces. The surfaces can reduce infections caused by pathogens such as S. aureus and E. coli and can be used on common plastics, medical devices, lenses and even ship hulls. Conventional methods for preventing bacterial surface attachment may use potentially harmful metal ions, nanoparticles, chemicals or UV-radiation.

5 Dec 2010

University of Portland's school of engineering named after Bjork-Shiley heart valve inventor

University of Portland's school of engineering will now be known as the Donald P. Shiley School of Engineering in recognition of the late Donald Shiley, a 1951 graduate who was an engineer, inventor, entrepreneur, businessman, philanthropist and loving husband and father. Among his many groundbreaking inventions was the Bjork-Shiley heart valve, an innovative medical device that has been credited with saving more than a half million lives.

4 Dec 2010

Appropriate level of Static Magnetic Field exposure for wound patients needs to be considered

The interest in the biological effects of non-ionizing Electro Magnetic Fields (EMFs) and Static Magnetic Fields (SMFs) on the whole organism, as well on cellular systems, has noticeably increased in recent years in consideration of their increased production (from the generation and transmission of electricity, to domestic appliances and industrial equipment, to telecommunications and broadcasting) and the possible health risk for humans.

4 Dec 2010

Technology News and Research

NanoString secures exclusive worldwide license to develop products for breast cancer intrinsic subtyping

Campaign to inoculate millions across Africa against meningitis kicks off in Burkina Faso

Research team creates digital version of Broselow tape for children

Smoking's effect on face induces women to quit the habit

Quantros to demonstrate new patient safety improvement solutions at IHI National Forum

Health experts, mobile service providers discuss potential for mobile health in Africa at summit

PAREXEL International opens two new Clinical Logistics Services facilities

Fraunhofer USA CMB receives FDA approval to initiate Phase I clinical trial of H5N1 influenza vaccine

Asuragen, Novartis to develop ARQ BCR-ABL1 RNA IS Calibrators, laboratory software reporting tools

HHS, U.S. Treasury Department recognize Integrated Medical Systems' technolgy

GP Medical, Beijing Yuande named in Deloitte Technology Fast 500 Asia Pacific 2010 program

MBH receives prestigious 2010 Healthcare IT Summit Innovation Award

HP, mPedigree Network introduce life-saving service to fight counterfeit drugs in Africa

First patient dosed with rFVIIIFc in A-LONG trial

Merrion Pharmaceuticals announces oral drug delivery Feasibility and Option agreement

Researchers adapt gene chip microarray technology to study glycans

Cerner, Baxa sign strategic reseller agreement for DoseEdge Pharmacy Workflow Manager

Marine life-inspired anti-microbial surfaces

University of Portland's school of engineering named after Bjork-Shiley heart valve inventor

Appropriate level of Static Magnetic Field exposure for wound patients needs to be considered

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News